Liquidia Corporation (LQDA) stock surged +0.04%, trading at $68.66 on NASDAQ, up from the previous close of $68.63. The stock opened at $67.91, fluctuating between $67.40 and $69.47 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 67.91 | 69.47 | 67.40 | 68.66 | 897.24K |
| Sep 03, 2026 | 69.27 | 70.75 | 68.15 | 68.63 | 931.5K |
| Sep 02, 2026 | 67.40 | 70.13 | 66.73 | 69.68 | 1.28M |
| Sep 01, 2026 | 67.70 | 69.00 | 66.10 | 66.91 | 1.41M |
| Aug 31, 2026 | 67.10 | 68.27 | 66.10 | 68.17 | 1.05M |
| Aug 28, 2026 | 69.99 | 70.31 | 67.57 | 67.69 | 923.37K |
| Aug 27, 2026 | 71.01 | 71.70 | 69.51 | 69.94 | 548.06K |
| Aug 26, 2026 | 70.14 | 72.96 | 70.00 | 71.36 | 845.31K |
| Aug 25, 2026 | 71.50 | 73.07 | 70.10 | 70.49 | 931.03K |
| Aug 24, 2026 | 67.77 | 71.11 | 67.25 | 70.27 | 1.29M |
| Aug 21, 2026 | 70.91 | 71.13 | 68.05 | 68.62 | 1.7M |
| Aug 20, 2026 | 73.55 | 74.53 | 70.85 | 71.05 | 1.58M |
| Aug 19, 2026 | 74.99 | 76.65 | 73.29 | 75.33 | 1.16M |
| Aug 18, 2026 | 76.20 | 76.77 | 72.83 | 74.33 | 1.45M |
| Aug 17, 2026 | 73.26 | 77.93 | 73.00 | 77.70 | 1.52M |
| Aug 14, 2026 | 71.98 | 76.90 | 71.53 | 74.44 | 2.52M |
| Aug 13, 2026 | 79.67 | 80.83 | 71.86 | 72.10 | 4.33M |
| Aug 12, 2026 | 83.64 | 86.91 | 78.34 | 78.79 | 3.98M |
| Aug 11, 2026 | 90.83 | 93.61 | 87.00 | 88.05 | 1.87M |
| Aug 10, 2026 | 89.94 | 92.36 | 87.62 | 91.03 | 1.65M |
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
| Employees | 216 |
| Beta | 0.57 |
| Sales or Revenue | $17.49M |
| 5Y Sales Change% | -0.288% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep